A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women

Amin Salehpour, Farhad Hosseinpanah, Farzad Shidfar, Mohammadreza Vafa, Maryam Razaghi, Sahar Dehghani, Anahita Hoshiarrad, Mahmoodreza Gohari, Amin Salehpour, Farhad Hosseinpanah, Farzad Shidfar, Mohammadreza Vafa, Maryam Razaghi, Sahar Dehghani, Anahita Hoshiarrad, Mahmoodreza Gohari

Abstract

Background: Vitamin D concentrations are linked to body composition indices, particularly body fat mass. Relationships between hypovitaminosis D and obesity, described by both BMI and waist circumference, have been mentioned. We have investigated the effect of a 12-week vitamin D3 supplementation on anthropometric indices in healthy overweight and obese women.

Methods: In a double-blind, randomized, placebo-controlled, parallel-group trial, seventy-seven participants (age 38 ± 8.1 years, BMI 29.8 ± 4.1 kg/m²) were randomly allocated into two groups: vitamin D (25 μg per day as cholecalciferol) and placebo (25 μg per day as lactose) for 12 weeks. Body weight, height, waist, hip, fat mass, 25(OH) D, iPTH, and dietary intakes were measured before and after the intervention.

Results: Serum 25(OH)D significantly increased in the vitamin D group compared to the placebo group (38.2 ± 32.7 nmol/L vs. 4.6 ± 14.8 nmol/L; P<0.001) and serum iPTH concentrations were decreased by vitamin D3 supplementation (-0.26 ± 0.57 pmol/L vs. 0.27 ± 0.56 pmol/L; P<0.001). Supplementation with vitamin D3 caused a statistically significant decrease in body fat mass in the vitamin D group compared to the placebo group (-2.7 ± 2.1 kg vs. -0.47 ± 2.1 kg; P<0.001). However, body weight and waist circumference did not change significantly in both groups. A significant reverse correlation between changes in serum 25(OH) D concentrations and body fat mass was observed (r = -0.319, P = 0.005).

Conclusion: Among healthy overweight and obese women, increasing 25(OH) D concentrations by vitamin D3 supplementation led to body fat mass reduction.

Trial registration: ClinicalTrials.gov NCT01344161.

Figures

Figure 1
Figure 1
Follow of participants throughout the intervention.
Figure 2
Figure 2
Relation between alterations of serum 25(OH) D concentrations and body fat mass.
Figure 3
Figure 3
Relation between alterations of serum iPTH concentrations and body fat mass.

References

    1. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in australia. Med J Aust. 2003;179:580–585.
    1. Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr. 2007;61:1373–1379. doi: 10.1038/sj.ejcn.1602656.
    1. Marieke B, Snijder MB, van Dam RM, Visser M, Deeg DJH, Dekker JM, Bouter LM, Seidell JC, Lips P. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005;90:4119–4123. doi: 10.1210/jc.2005-0216.
    1. Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–362.
    1. Wareham N. Physical activity and obesity prevention. Obes Rev. 2007;8(Suppl):109–114.
    1. Buffington C, Walker B, Cowan GS, Scruggs D. Vitamin D deficiency in morbidly obese. Obes Surg. 1993;3:421–424. doi: 10.1381/096089293765559142.
    1. Zamboni G, Soffiati M, Giavarina D, Tato L. Mineral metabolism in obese children. Acta Paediatr Scand. 1988;77:741–746. doi: 10.1111/j.1651-2227.1988.tb10740.x.
    1. Yanoff LB, Parikh SJ, Spitalnik A, Denkinger B, Sebring NG, Slaughter P, McHugh T, Remaley AT, Yanovski JA. The prevalence of hypovitaminosis d and secondary hyperparathyroidism in obese black americans. Clin Endocrinol. 2006;64:s23–s29.
    1. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin d in obesity. Calcif Tissue Int. 1988;43:199–201. doi: 10.1007/BF02555135.
    1. Danescu LG, Levy S, Levy J. Vitamin d and diabetes mellitus. Endocrine. 2009;35:11–7. doi: 10.1007/s12020-008-9115-5.
    1. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin d endocrine system in obese subjects. J Clin Invest. 1985;76:370–373. doi: 10.1172/JCI111971.
    1. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin d levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181:699–704. doi: 10.1164/rccm.200911-1710OC.
    1. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD. Integration of npy, agrp, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron. 1999;24(Suppl 1):155–163.
    1. Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardio Ther. 2008;6:343–368. doi: 10.1586/14779072.6.3.343.
    1. Schwartz MW, Niswender KD. Adiposity signaling and biological defense against weight gain: absence of protection or central hormone resistance? J Clin Endocrinol Metab. 2004;89(Suppl 12):5889–5897.
    1. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, Pennathur S, Baskin DG, Heinecke JW, Woods SC, Schwartz MW, Niswender KD. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab. 2009;296:E1003–E1012. doi: 10.1152/ajpendo.90377.2008.
    1. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin d in obesity. Am J Clin Nutr. 2000;72:690–693.
    1. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132–1138.
    1. Teegarden D. Calcium intake and reduction of fat mass. J Nutr. 2003;133:249S–251S.
    1. Zemel MB. Proposed role of calcium and dairy food components in weight management and metabolic health. Physician Sport Med. 2009;37:29–39.
    1. Spence LA, Cifelli CJ, Miller GD. The role of dairy products in healthy weight and body composition in children and adolescents. Curr Nutr Food Sci. 2011;7(Suppl 1):40–49(10).
    1. Ochs-Balcom HM, Chennamaneni R, Millen AE, Shields PG, Marian C, Trevisan M, Freudenheim JL. Vitamin d receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr. 2011;93:5–10. doi: 10.3945/ajcn.2010.29986.
    1. Wood RJ. Vitamin d and adipogenesis: new molecular insights. Nutr Rev. 2008;66:40–46. doi: 10.1111/j.1753-4887.2007.00004.x.
    1. Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin d3 inhibition of adipogenesis in 3 T3-L1 cells. Am J Physiol Endocrinol Metab. 2006;290:E916–E924. doi: 10.1152/ajpendo.00410.2005.
    1. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr. 2002;21:146S–151S.
    1. Hosseini Esfahani F, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the tehran lipid and glucose study. J Epidemiol. 2010;20:150–158. doi: 10.2188/jea.JE20090083.
    1. Azar M, Sarkisian E. Food Composition Table of Iran. National Nutrition and Food Research Institute, Shaheed Beheshti University, Tehran; 1980.
    1. .
    1. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exercise. 2003;35:1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB.
    1. World Health Organization Physical Status. The Use 478 and Interpretation of Anthropometry. Technical Report 479 Series no. 854. WHO, Geneva; 1995.
    1. Siddiqui SM, Chang E, Li J, Burlage C, Zou M, Buhman KK, Koser S, Donkin SS, Teegarden D. Dietary intervention with vitamin d, calcium, and whey protein reduced fat mass and increased lean mass in rats. Nutr Res. 2008;28:783–790. doi: 10.1016/j.nutres.2008.08.004.
    1. Rosenblum JL, Castro VM, Moore CE, Kaplan LM. Calcium and vitamin d supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr. 2012;95(Suppl 1):101–108.
    1. Adams JS, Hewison M. Update in vitamin d. J Clin Endocrinol Metab. 2010;95:471–478. doi: 10.1210/jc.2009-1773.
    1. Reid IR. Relationships between fat and bone. Osteoporos Int. 2008;19:595–606. doi: 10.1007/s00198-007-0492-z.
    1. Ward KA, Das G, Berry JL, Roberts SA, Rawer R, Adams JE, Mughal Z. Vitamin d status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab. 2009;9:559–563.
    1. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo D, Thomas J, Pierce GL, White J, Holick MF, Zhu H. A 16-week randomized clinical trial of 2000 international units daily vitamin d3 supplementation in black youth: 25-hydroxyvitamin d, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010;95:4584–4591. doi: 10.1210/jc.2010-0606.
    1. Zhou J, Zhao LJ, Watson P, Zhang Q, Lappe JM. The effect of calcium and vitamin d supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab. 2010;7:62–70. doi: 10.1186/1743-7075-7-62.
    1. Major GC, Alarie FP, Dore J, Tremblay A. Calcium plus vitamin d supplementation and fat mass loss in female very low-calcium consumers: potential link with a calcium-specific appetite control. Brit J Nutr. 2009;101:659–663. doi: 10.1017/S0007114508030808.
    1. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R. Vitamin d supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89:1321–1327. doi: 10.3945/ajcn.2008.27004.
    1. Begum N, Sussman KE, Draznin B. Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is mediated by the phosphorylation and activation of inhibitor 1. J Biol Chem. 1992;267:5959–5963.
    1. Ni Z, Smogorzewski M, Massry SG. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology. 1994;135:1837–1844. doi: 10.1210/en.135.5.1837.
    1. Xue B, Greenberg AG, Kraemer FB, Zemel MB. Mechanism of intracellular calcium ([ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J. 2001;15:2527–2529.
    1. Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Zemel MB. The effects of calcium channel blockade on agouti-induced obesity. FASEB J. 1996;10:1646–1652.
    1. Shrago E, Spennetta T. The carbon pathway for lipogenesis in isolated adipocytes from rat, guinea pig, and human adipose tissue. Am J Clin Nutr. 1976;29:540–545.
    1. Guo ZK, Cella LK, Baum C, Ravussin E, Schoeller DA. De novo lipogenesis in adipose tissue of lean and obese women: application of deuterated water and isotope ratio mass spectrometry. Int J Obes Relat Metab Disord. 2000;24:932–937. doi: 10.1038/sj.ijo.0801256.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren